Potentiation of Neuronal Nicotinic Receptors by Zinc
锌对神经元烟碱受体的增强作用
基本信息
- 批准号:7231666
- 负责人:
- 金额:$ 32.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-06-01 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcetylcholineAgonistAlzheimer&aposs DiseaseAmino AcidsAnalgesicsAnti-Anxiety AgentsBindingBinding ProteinsBinding SitesCentral Nervous System DiseasesChemosensitizationClassClassificationCysteineDNA Sequence RearrangementDevelopmentExtracellular DomainGene FamilyGoalsHomology ModelingInterventionIonsKineticsLeftLigandsMediatingMethodologyModelingMuscleMutagenesisNeuronsNeurotransmitter ReceptorNicotineNicotinic ReceptorsNumbersParkinson DiseasePathway interactionsProbabilityProcessRateReceptor ActivationResearch PersonnelRoleSchizophreniaSiteSite-Directed MutagenesisStructureThinkingZincdrug developmentinterestmethanethiosulfonatenervous system disorderpatch clampprogramsreceptorreceptor functionresearch study
项目摘要
DESCRIPTION (provided by applicant): The goals of this project are: (1) to elucidate the structure of the site(s) on neuronal nicotinic acetylcholine receptors (nAChRs) where zinc binds and potentiates receptor function, and (2) to elucidate the mechanism through which zinc potentiates receptor function.
Nicotinic ligands are potentially useful as anxiolytics and analgesics, in the treatment of neurological disorders such as schizophrenia, Parkinson's disease, and Alzheimer's disease, and are also the sites at which nicotine exerts its psychoactive and addictive effects. Effective pharmacological intervention at neuronal nAChRs requires development of subtype selective ligands. Pursuit of this goal has traditionally been directed toward development of ligands that act at the acetylcholine (ACh) binding sites. We propose to pursue a new class of site on neuronal nAChRs, the site at which zinc potentiates these receptors. The ACh binding sites on neuronal nAChRs are at the interfaces between the extracellular domains of subunits. In many neuronal nAChRs, two agonist-binding sites are formed at interfaces between two pairs of dissimilar subunits, leaving three alternate interfaces with no involvement in ACh binding. We hypothesize that one or more of the alternate interfaces bind zinc, a modulator of neuronal nAChR function. In aim 1, we will use site-directed mutagenesis and functional analysis to identify amino acid residues on neuronal nAChRs that coordinate zinc at the potentiation site. In aim 2, we will explore the larger structure of the potentiation site using Substituted Cysteine Accessibility Mutagenesis. Information obtained in aims 1 and 2 will be used to refine a homology model of the extracellular domains of neuronal nAChRs. In aim 3, we will determine whether zinc potentiates neuronal nAChRs through changes in the single channel open probability, the single channel current, and/or the number of channels. Changes in open probability will be characterized in terms of the underlying gating mechanism.
描述(由申请人提供):本项目的目标是:(1)阐明锌结合并增强受体功能的神经元烟碱乙酰胆碱受体(nAChR)位点的结构,以及(2)阐明锌增强受体功能的机制。
烟碱配体可用作抗焦虑药和镇痛药,用于治疗神经系统疾病,如精神分裂症、帕金森病和阿尔茨海默病,并且也是烟碱发挥其精神活性和成瘾作用的位点。神经元nAChRs的有效药物干预需要亚型选择性配体的开发。追求这一目标,传统上是针对开发的配体,在乙酰胆碱(ACh)的结合位点的行为。我们建议追求一类新的网站上的神经元乙酰胆碱受体,锌增强这些受体的网站。神经元nAChR上的ACh结合位点位于亚基细胞外结构域之间的界面处。在许多神经元nAChRs中,两个激动剂结合位点在两对不同亚基之间的界面处形成,留下三个不参与ACh结合的交替界面。我们假设一个或多个交替接口结合锌,神经元nAChR功能的调制器。在目标1中,我们将使用定点诱变和功能分析,以确定氨基酸残基的神经元乙酰胆碱受体,协调锌的增效位点。在目标2中,我们将使用取代的半胱氨酸可及性突变来探索增强位点的更大结构。在目标1和2中获得的信息将用于改进神经元nAChR的胞外结构域的同源性模型。在目标3中,我们将通过单通道开放概率、单通道电流和/或通道数量的变化来确定锌是否增强神经元nAChR。开放概率的变化将根据潜在的门控机制进行表征。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charles Ward Luetje其他文献
Charles Ward Luetje的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charles Ward Luetje', 18)}}的其他基金
Binding Site Structure of Insect Odorant Receptors.
昆虫气味受体的结合位点结构。
- 批准号:
8077279 - 财政年份:2010
- 资助金额:
$ 32.1万 - 项目类别:
Binding Site Structure of Insect Odorant Receptors.
昆虫气味受体的结合位点结构。
- 批准号:
8661155 - 财政年份:2010
- 资助金额:
$ 32.1万 - 项目类别:
Binding Site Structure of Insect Odorant Receptors.
昆虫气味受体的结合位点结构。
- 批准号:
8461225 - 财政年份:2010
- 资助金额:
$ 32.1万 - 项目类别:
Binding Site Structure of Insect Odorant Receptors.
昆虫气味受体的结合位点结构。
- 批准号:
8271457 - 财政年份:2010
- 资助金额:
$ 32.1万 - 项目类别:
Ligand Recognition Among Mammalian Odorant Receptors
哺乳动物气味受体中的配体识别
- 批准号:
7465088 - 财政年份:2008
- 资助金额:
$ 32.1万 - 项目类别:
Ligand Recognition Among Mammalian Odorant Receptors
哺乳动物气味受体中的配体识别
- 批准号:
7788147 - 财政年份:2008
- 资助金额:
$ 32.1万 - 项目类别:
Ligand Recognition Among Mammalian Odorant Receptors
哺乳动物气味受体中的配体识别
- 批准号:
7569969 - 财政年份:2008
- 资助金额:
$ 32.1万 - 项目类别:
Potentiation of Neuronal Nicotinic Receptors by Zinc
锌对神经元烟碱受体的增强作用
- 批准号:
6897925 - 财政年份:2003
- 资助金额:
$ 32.1万 - 项目类别:
Potentiation of Neuronal Nicotinic Receptors by Zinc
锌对神经元烟碱受体的增强作用
- 批准号:
7061608 - 财政年份:2003
- 资助金额:
$ 32.1万 - 项目类别:
Potential of Neuronal Nicotinic Receptors by Zinc
锌对神经元烟碱受体的潜力
- 批准号:
6612429 - 财政年份:2003
- 资助金额:
$ 32.1万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 32.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 32.1万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 32.1万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 32.1万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 32.1万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 32.1万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 32.1万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 32.1万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 32.1万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 32.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)